A clinical research of Apatinib unite chemotherapy in second-line treatment of advanced lung cancer, gastric cancer and colorectal cancer

ABSTRACT: Interventions: Case series:combination of apatinib based on the second-line chemotherapy Primary outcome(s): Progression-Free-Survival;disease control rates;objective response rate Study Design: Non randomized control

DISEASE(S): Cancer

PROVIDER: 2670970 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR